Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-02-17FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original application for ziprasidone hydrochloride, granting a generic version of ziprasidon…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Insulin Resistance in Patients With Mood Disorder [NA]
This clinical trial update reports completion and posted results of a study exploring insulin resistance in patients with mood disorders, in…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram [Phase 2, Phase 3]
This clinical trial update reports Phase 2 and Phase 3 results for using citalopram to treat acute bipolar depression and to examine prophyl…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder [Phase 4]
Phase 4 study investigating predictors of response to augmentation with ziprasidone (Geodon) in major depressive disorder, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: An fMRI Study on Temporal Discounting in Bipolar Disorder
This is a completed clinical trial from Massachusetts General Hospital using fMRI to study temporal discounting in individuals with bipolar …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes [Phase 2, Phase 3]
The clinical trial evaluating FK949E for major depressive episodes in bipolar disorder has completed Phase 2 and Phase 3, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Lurasidone and Cognition in Bipolar I Disorder [Phase 3]
A Phase 3 study evaluating lurasidone for cognitive outcomes in Bipolar I Disorder has completed.
-
FDA approval · 2017-02-01FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone submitted by Ajanta Pharma USA Inc. The approval indicates updated labeling and pote…
-
FDA approval · 2017-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole (generic ARIPIPRAZOLE) from Amneal Pharmaceuticals LLC, authorizing the generic for…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients
A completed clinical trial evaluating how adults with bipolar disorder adhere to their prescribed medications.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Pioglitazone for the Treatment of Bipolar Depression [Phase 4]
Phase 4 trial evaluating pioglitazone for bipolar depression was terminated. Results were posted on 2017-01-27.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A completed pilot cohort study assessing how common comorbid mental illness and substance use disorders are, including schizophrenia and rel…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Lamotrigine Phase III Study in Bipolar I Disorder [Phase 3]
This update reports the completion of a Phase 3 trial evaluating lamotrigine in Bipolar Disorder, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy [NA]
A randomized controlled trial evaluated electroconvulsive therapy for treatment-resistant depression in bipolar disorder; the study has comp…
-
FDA approval · 2017-01-13FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAPHRIS (asenapine) filed by Allergan, Inc., indicating an update to the product's labeling/indi…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Phase 3]
This open-label Phase 3 trial evaluated ziprasidone for treating psychosis-related disorders in adolescents, including schizophreniform diso…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Modifying Group Therapy for Bipolar Substance Abusers - 1 [NA]
A completed clinical trial evaluating a modified group therapy approach for individuals with bipolar disorder and substance use disorder.
-
FDA approval · 2017-01-11FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc. to update labeling.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder [Phase 1, Phase 2]
This report summarizes a completed Phase 1/2 trial evaluating sustained-release bupropion for smoking cessation. The study enrolled individu…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder [Phase 4]
Phase 4 trial update reports the results of adjunctive topiramate for treating alcohol dependence in patients with bipolar disorder; the stu…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Contingency Management of Alcohol Abuse in the Severely Mentally ILL [NA]
This clinical trial update reports the completed results of a contingency management intervention for alcohol use disorder in individuals wi…
-
FDA approval · 2016-12-27FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' ziprasidone hydrochloride as a generic from an Abbreviated New Drug Application. The approval covers th…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Culturally Adapted Psychological Intervention for Bipolar Disorder in Pakistan [NA]
A completed clinical trial in Pakistan evaluated a culturally adapted psychological intervention for bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression [Phase 3]
Phase 3 clinical trial evaluating adjunctive minocycline for bipolar depression has completed.
-
CLINICAL_TRIALS research · 2016-12-09Clinical Trial Update: Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints [NA]
Clinical trial evaluating cognitive remediation for euthymic bipolar patients with memory complaints, sponsored by University Hospital, Mont…